Mirum Pharmaceuticals (MIRM) Change in Receivables (2022 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Change in Receivables of $12.9 million for Q1 2026, down 23.45% year-over-year from $16.8 million in Q1 2025, and down 32.21% quarter-over-quarter from $19.0 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Change in Receivables (2022 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Change in Receivables history runs 5 years deep, the most recent figure standing at $12.9 million for Q1 2026.
- In Q1 2026, Change in Receivables fell 23.45% year-over-year to $12.9 million; the TTM figure through Mar 2026 stood at $44.1 million (up 6.99% YoY), while the FY2025 annual figure was $48.1 million, up 320.58% from the prior year.
- Change in Receivables for Q1 2026 stood at $12.9 million, down from $19.0 million in the prior quarter.
- The five-year high for Change in Receivables was $20.1 million in Q4 2023, with the low at -$13.0 million in Q1 2024.
- The 5-year median for Change in Receivables is $8.1 million (2024), against an average of $8.1 million.
- The sharpest annual moves came in 2023 and 2024: Change in Receivables soared 432.94% in 2023, then tumbled 2044.38% in 2024.
- Mirum Pharmaceuticals' Change in Receivables stood at $7.7 million in 2022, then surged by 162.95% to $20.1 million in 2023, then plunged by 46.04% to $10.9 million in 2024, then jumped by 74.96% to $19.0 million in 2025, then tumbled by 32.21% to $12.9 million in 2026.
- Business Quant data shows MIRM's Change in Receivables at $12.9 million in Q1 2026, $19.0 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | 13.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.74 Mn |
| Jun 30, 2026 | 13.74 Mn |
| Mar 31, 2026 | 12.89 Mn |
| Mar 31, 2026 | 12.89 Mn |
| Dec 31, 2025 | 19.01 Mn |
| Dec 31, 2025 | 19.01 Mn |
| Sep 30, 2025 | 3.15 Mn |
| Sep 30, 2025 | 3.15 Mn |
| Jun 30, 2025 | 9.07 Mn |
| Jun 30, 2025 | 9.07 Mn |
| Mar 31, 2025 | 16.83 Mn |
| Mar 31, 2025 | 16.83 Mn |
| Dec 31, 2024 | 10.86 Mn |
| Dec 31, 2024 | 10.86 Mn |
| Sep 30, 2024 | 8.10 Mn |
| Sep 30, 2024 | 8.10 Mn |
| Jun 30, 2024 | 5.43 Mn |
| Jun 30, 2024 | 5.43 Mn |
| Mar 31, 2024 | -12.97 Mn |
| Mar 31, 2024 | -12.97 Mn |